Cargando…
Discovery of Novel Indolealkylpiperazine Derivatives as Potent 5-HT(1A) Receptor Agonists for the Potential Future Treatment of Depression
Depression is a severe psychiatric disorder that affects over 100 million people worldwide. 5-HT(1A) receptor agonists have been implicated in the treatment of a variety of central nervous system diseases, especially depression. In this study, based on FW01, a selective potent 5-HT(1A)R agonist disc...
Autores principales: | Zhu, Chen, Li, Xinwei, Peng, Weiqing, Fu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662226/ https://www.ncbi.nlm.nih.gov/pubmed/33139658 http://dx.doi.org/10.3390/molecules25215078 |
Ejemplares similares
-
Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021) -
Discovery of
β-Arrestin-Biased
25CN-NBOH-Derived
5-HT(2A) Receptor Agonists
por: Poulie, Christian B. M., et al.
Publicado: (2022) -
The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties
por: Beattie, David T., et al.
Publicado: (2011) -
Identification of a Potent and Selective 5-HT(1A) Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity
por: Linciano, Pasquale, et al.
Publicado: (2020) -
Chronic Administration of 5-HT1A Receptor Agonist Relieves Depression and Depression-Induced Hypoalgesia
por: Jiang, Zhao-Cai, et al.
Publicado: (2014)